Results 141 to 150 of about 1,506 (153)
Some of the next articles are maybe not open access.
The Rebirth of Lebrikizumab for Airway Disease
The Journal of Allergy and Clinical Immunology: In Practiceopenaire +2 more sources
Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis
British Journal of Dermatology, 2023openaire +2 more sources
Successful Treatment of Bullous Pemphigoid with Lebrikizumab: A Case Report
JDDG: Journal der Deutschen Dermatologischen GesellschaftLisa Grentner +3 more
openaire +2 more sources
Lebrikizumab - nová možnost léčby atopické dermatitidy
Atopic dermatitis (AD) is a chronic inflammatory skin disease that primarily affects children and often persists into adulthood. Its etiology is multifactorial, with a significant role played by genetic predisposition, impaired skin barrier function, and dysregulation of the immune system, particularly Th2 response.openaire +1 more source
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge
Clinical and Experimental Allergy, 2014exaly
75474 Lebrikizumab for Refractory Atopic Dermatitis
Journal of the American Academy of DermatologyNatalia Chalupczak, Peter Lio
openaire +1 more source
Lebrikizumab approval for the treatment of moderate to severe atopic dermatitis in Italy
Italian Journal of Dermatology and VenereologyArgenziano, Giuseppe +3 more
openaire +2 more sources